Data indicate that NF-kappaB-sensitive miRNA-146a-mediated modulation of CFH gene expression may in part regulate an inflammatory response in AD brain and in stressed HN cell models of AD, and illustrate the potential for anti-miRNAs as an effective therapeutic strategy against pathogenic inflammatory signaling. This evidence concerns the gene CFH and Alzheimer disease.